Mosapride for gastroesophageal reflux disease in neurologically impaired patients
Sign Up to like & getrecommendations! Published in 2017 at "Pediatrics International"
DOI: 10.1111/ped.13144
Abstract: The prokinetic agent cisapride is effective for the treatment of gastroesophageal reflux disease (GERD) in infants and children, but is no longer used for this purpose because of safety concerns. Therefore, other pharmacological agents need… read more here.
Keywords: mosapride gastroesophageal; neurologically impaired; reflux disease; gastroesophageal reflux ... See more keywords